Association between new indices in the locomotive syndrome risk test and decline in mobility: third survey of the ROAD study  by Yoshimura, Noriko et al.
J Orthop Sci (2015) 20:896–905
DOI 10.1007/s00776-015-0741-5
1 3
ORIGINAL ARTICLE
Association between new indices in the locomotive syndrome risk 
test and decline in mobility: third survey of the ROAD study
Noriko Yoshimura1 · Shigeyuki Muraki2 · Hiroyuki Oka3 · Sakae Tanaka4 · 
Toru Ogata5 · Hiroshi Kawaguchi6 · Toru Akune5 · Kozo Nakamura5 
Received: 5 December 2014 / Accepted: 29 May 2015 / Published online: 25 June 2015 
Results We first estimated the prevalence of the indices 
in locomotive syndrome risk test stage 1, including two-
step test score <1.3, difficulty with one-leg standing from 
a 40-cm-high seat in the stand-up test, and 25-question 
GLFS score ≥7, which were found to be 57.4, 40.6, and 
22.6 %, respectively. Next, we investigated the prevalence 
of the indices in locomotive syndrome risk test stage 2, 
including two-step test score <1.1, difficulty with standing 
from a 20-cm-high seat using both legs in the stand-up test, 
and 25-question GLFS score ≥16, which were found to 
be 21.1, 7.9, and 10.6 %, respectively. Logistic regression 
analysis using slow FTSST time or slow walking speed 
as the objective factor, and presence or absence of indices 
as the independent factor, after adjusting for confound-
ers, showed all three indices in both stages 1 and 2 were 
significantly and independently associated with immobil-
ity. Finally, we clarified the risk of immobility according 
to an increasing number of indices in both stages 1 and 2 
and found that the odds ratio for both slow FTSST time and 
slow walking speed increased exponentially.
Conclusion We found that the three indices indepen-
dently predicted immobility and that accumulation of indi-
ces increased the risk of immobility exponentially.
Introduction
According to the most recent National Livelihood Survey 
by the Ministry of Health, Labour, and Welfare in Japan, 
osteoporotic fracture and falls is ranked fourth and osteoar-
thritis is ranked fifth among conditions that cause disability 
and subsequently require support with regard to activities of 
daily living [1]. Given the increasing proportion of elderly 
individuals in the Japanese population, a comprehensive 
and evidence-based prevention strategy for musculoskeletal 
Abstract 
Background We aimed to clarify the association between 
new indices in a locomotive syndrome risk test and decline 
in mobility.
Methods In the third survey of the Research on Osteo-
arthritis/osteoporosis Against Disability (ROAD) study, 
data on the indices were obtained from 1575 subjects (513 
men, 1062 women) of the 1721 participants in mountain-
ous and coastal areas. As outcome measures for decline in 
mobility, we used the five-times-sit-to-stand test (FTSST) 
and walking speed with cutoff values of 12 s and 0.8 m/s, 
respectively.
Electronic supplementary material The online version of this 
article (doi:10.1007/s00776-015-0741-5) contains supplementary 
material, which is available to authorized users.
 * Noriko Yoshimura 
 yoshimuran-ort@h.u-tokyo.ac.jp
1 Department of Joint Disease Research, 22nd Century 
Medical and Research Center, The University of Tokyo, 
Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan
2 Department of Clinical Motor System Medicine, 22nd 
Century Medical and Research Center, The University 
of Tokyo, Tokyo 113-8655, Japan
3 Department of Medical Research and Management 
for Musculoskeletal Pain, 22nd Century Medical 
and Research Center, The University of Tokyo, 
Tokyo 113-8655, Japan
4 Department of Orthopaedic Surgery, Sensory and Motor 
System Medicine, Graduate School of Medicine,  
The University of Tokyo, Tokyo 113-8655, Japan
5 National Rehabilitation Center for Persons with Disabilities, 
Saitama 359-0042, Japan
6 JCHO Tokyo Shinjuku Medical Center, Tokyo 162-8542, 
Japan
© 2015 The Author(s). Published by Elsevier B.V.  CC BY license This is an open access article under the
897Association between new indices in the locomotive syndrome risk test and decline in mobility…
1 3
diseases is urgently required. In 2007, the Japanese Ortho-
paedic Association (JOA) proposed that the term “locomo-
tive syndrome” should be adopted to designate a condition 
requiring nursing care, or being at risk of developing such a 
condition, because of a decline in mobility resulting from a 
disorder of the locomotive system, which consists of bones, 
joints, muscles, and nerves [2]. Weakness of such locomo-
tive components causes difficulty in mobility—defined as 
the ability to stand, walk, run, climb stairs, and perform 
other physical functions essential to daily life.
As candidate indices to assess the risk of locomotive 
syndrome, in 2013, the JOA proposed the following three 
tests: two-step test, stand-up test, and 25-question geriatric 
locomotive function scale (GLFS) [3]. With regard to the 
stand-up test, more than 50 % of subjects younger than 
70 years old can stand up on one leg from a 40-cm-high 
seat [3]. The 25-question GLFS has already been assessed 
regarding its sensitivity and specificity for prediction of 
disability and was assigned a cutoff value of 16 by Seichi 
et al. [4]. However, there is little information regarding ref-
erence and/or cutoff values for the two-step test.
Recently, the JOA determined clinical decision limits 
of these three indices for assessing risk of locomotive syn-
drome [5]. In their proposal, clinical decision limits were 
established in two stages as follows:
Stage 1:
1. Two-step test score <1.3.
2. Difficulty with one-leg standing from a 40-cm-high 
seat in the stand-up test (either leg).
3. 25-question GLFS score ≥7.
When a subject meets any of the above-mentioned 
conditions, he/she is diagnosed as starting to decline in 
mobility.
Stage 2:
1. Two-step test score <1.1.
2. Difficulty with standing from a 20-cm-high seat using 
both legs in the stand-up test.
3. A 25-question GLFS score ≥16.
When a subject meets any of the above-mentioned con-
ditions, he/she is diagnosed as progressing to a decline in 
mobility.
However, no report has evaluated such indices using data 
of the general population. From 2005 to 2007, we started 
a large-scale, population-based cohort investigation enti-
tled the Research on Osteoarthritis/osteoporosis Against 
Disability (ROAD) study, consisting of 3040 participants 
in three communities located in urban, mountainous, and 
coastal areas. Following the baseline study, we performed a 
second survey in the same communities from October 2008 
to January 2010, followed by a third survey from October 
2012 to December 2013. In the third survey, participants 
completed the two-step test, stand-up test, and 25-question 
GLFS. In the present report, using data from the third sur-
vey of the ROAD study, we assessed the usefulness of these 
new indices for predicting immobility, which causes subse-
quent disability.
Participants and methods
Participants
Measurements were obtained from participants of the 
third survey of the ROAD study. The ROAD study, which 
began in 2005, is a nationwide prospective study compris-
ing population-based cohorts established in several com-
munities in Japan. Recruitment methods for this study have 
been described in detail elsewhere [6, 7]. To date, we have 
created a baseline database including clinical and genetic 
information of 3040 inhabitants (1061 men; 1979 women) 
aged 23–95 years who were recruited from listings of resi-
dent registrations in three communities. All participants 
provided written informed consent, and the study was con-
ducted with approval from the ethics committees of the 
participating institutions.
The third survey of the ROAD study began in 2012 and 
was completed in 2013. All participants in the baseline 
study and second survey were invited to participate in the 
third survey. Besides former participants, inhabitants aged 
≥40 years who were willing to attend the ROAD survey 
performed in 2012–2013 also were included as participants 
in the third survey. As a result, a total of 2566 (837 men, 
1729 women; urban area, 845 individuals; mountainous 
area, 769 individuals; coastal area, 952 individuals) resi-
dents participated in the third survey.
In the present study, we used data from 1575 subjects 
(513 men; 1062 women) who completed the stand-up test, 
two-step test, and 25-question GLFS for disability among 
all 1721 participants in mountainous and coastal areas in 
the third survey.
At the third survey, participants completed an inter-
viewer-administered questionnaire. Five interviewers, who 
had been trained by an expert (NY), were provided for 
this study. The questionnaire consisted of 200 items that 
included lifestyle information, such as primary occupation, 
smoking habits, alcohol consumption, physical activity, 
medical history, and prescription medication. Anthropo-
metric measurements included height (cm), weight (kg), 
body mass index [BMI, weight (kg)/height (m)2], and hand 
grip strength (kg).
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Indices for risk of decline in mobility resulting 
from locomotive syndrome
In the present study, participants performed the following 
tests for assessment of decline in mobility.
Two‑step test
This test measures the stride length to assess walking abil-
ity, including muscle strength, balance, and flexibility of 
the lower limbs. The two-step test was performed using the 
following procedure [3, 8, 9]: (1) subjects determined the 
starting line and stood with the toes of both feet behind it; 
(2) subjects were instructed to take two long steps (as long 
as possible) and then align both feet; (3) the length of the 
two steps from the starting line to the tips of the subject’s 
toes where he/she stopped was measured. The two-step test 
score was calculated using the following formula: length of 
the two steps (cm) ÷ height (cm).
Stand‑up test
This test assesses leg strength by having the subject stand 
up on one or both legs from a specified height. After prep-
aration of four seats of different heights—40, 30, 20, and 
10 cm—the subject stood up from each seat (in descend-
ing height order), first with both legs then with one leg. 
If the subject could stand up without leaning back to gain 
momentum and maintain the posture for 3 s, then he/she 
was diagnosed as having passed that height level [3, 9]. In 
the present study, if the subject was unable to stand up on 
one leg (right or left) from a height of 40 cm, then his/her 
stand-up test was considered failed.
The 25‑Question GLFS
As mentioned above, the 25-question GLFS was devel-
oped by Seichi et al. [4]. It is a self-administered, com-
prehensive measure, consisting of 25 items that include 
four questions regarding pain during the last month, 16 
questions regarding activities of daily living during the last 
month, three questions regarding social functions, and two 
questions regarding mental health status during the last 
month. These 25 items are graded with a five-point scale, 
from no impairment (0 points) to severe impairment (4 
points), and then arithmetically added to produce a total 
score (minimum = 0, maximum = 100). Thus, a higher 
score is associated with worse locomotive function. Valid-
ity of the scale has been assessed, and a cutoff point of 16 
was determined to have the highest sensitivity and speci-
ficity for indication of disability resulting from locomotive 
syndrome [3, 4].
Indices for decline in mobility resulting 
from locomotive syndrome
Because the present study utilized a cross-sectional design, 
not a longitudinal follow-up design, we could not evalu-
ate the ability of the stand-up test or two-step test for pre-
diction of disability resulting from locomotive syndrome. 
Therefore, in the present study, we used the following out-
come measures as indices for decline in mobility.
Five‑times‑sit‑to‑stand test
There are several reports that inability to rise from a chair 
five times within a determined time is associated with 
increased disability and morbidity [10–12]. We have also 
reported that the longer the standing time is, the higher the 
incidence of disability [13]. The five-times-sit-to-stand test 
(FTSST) was performed according to the following pro-
cedure: (1) using a straight-back chair with a solid seat, 
participants were asked to sit on the chair with their arms 
folded across their chest; (2) participants were instructed 
to stand up and sit down as quickly as possible five times, 
keeping their arms folded across their chest; (3) the time 
when the participant stood for the fifth time was measured. 
In the present study, we used a cutoff value of 12 s to indi-
cate a decline in mobility [14].
The 6‑m walking time
As another outcome measure for decline in mobility, par-
ticipants walked a 6-m course at their usual speed. The 
method of measurement of walking time was identical 
to that performed in the large-scale cohort study entitled 
Osteoporotic Fractures in Men (MrOS), which started prior 
to the ROAD study [15]. In the present study, we used a 
cutoff value of 0.8 m/s to indicate a decline in mobility 
[16].
In the present study, among the above-mentioned indi-
ces, mean scores and SDs for the two-step test were cal-
culated according to participants’ sex and age strata (<40, 
40s, 50s, 60s, 70s, and ≥80 years). Then, we estimated 
the prevalence of each index in stages 1 and 2. Finally, we 
assessed the association between the cumulative number of 
indices and decline in mobility using multivariate analysis.
Statistical analysis
All statistical analyses were performed using STATA statis-
tical software (STATA, College Station, TX, USA). Differ-
ences in proportions were compared using the chi-square 
test. The significance of differences in continuous variables 
was evaluated using analysis of variance for comparisons 
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among multiple groups or Scheffe’s least significant differ-
ence test for pairs of groups. All p values and 95 % confi-
dence intervals are two-sided. A p value of <0.05 was con-
sidered statistically significant.
Logistic regression analysis was used to test the associa-
tion of each factor with the presence or absence of a decline 
in mobility. In the analysis, we used presence of immobil-
ity according to the FTSST time (>12 s = 1; ≤12 s = 0) 
and usual walking speed (<0.8 m/s = 1; ≥0.8 m/s = 0) 
as the objective variable, and presence or absence of new 
indices in stages 1 and 2 as explanatory variables, after 
adjusting for age (+1 year), sex (men = 0, women = 1), 
BMI (+1 kg/m2), and regional difference (mountainous 
area = 0; coastal area = 1). Other factors were considered 
in the multivariate model after simple linear analysis; those 
used as explanatory factors are described in “Results.”
Results
Summary characteristics, including age and BMI of the 
participants, are shown in Table 1. Two-thirds of the 1575 
participants were women, and the mean age of women 
participants was 1 year less than that of men participants; 
however, this difference was not significant. By contrast, 
there was a significant difference in BMI between sexes 
(p < 0.0001). Table 1 also shows the age and sex distribu-
tions of mean FTSST time and walking speed. Both val-
ues tended to be significantly slower in participants aged 
in their 70s and 80s in both men and women, and there 
were no significant differences between sexes. Table 1 
also shows the age and sex distributions of mean two-step 
test scores. Mean two-step test score was 1.25 (SD 0.20) 
in men and 1.23 (SD 0.21) in women; this difference was 
significant (p < 0.0001). Age differences indicated that the 
two-step test score was significantly lower according to age 
in both men and women (p < 0.05).
First, the prevalence of the indices in stage 1 and 
their association with decline in mobility described by 
slow FTSST time and slow walking speed were assessed 
(Table 2). Overall, the prevalence of two-step test score 
<1.3, difficulty with one-leg standing from a 40-cm-high 
seat in the stand-up test, and 25-question GLFS score ≥7 
were 57.4, 40.6, and 22.6 %, respectively.
Prevalence of two-step test score <1.3 in subjects aged 
in their 30s and younger, 40s, 50s, 60s, 70s, and 80 years 
and older were 17.0, 28.5, 32.6, 51.5, 76.2, and 90.0 %, 
respectively, indicating that the prevalence increased 
according to age; even in subjects aged in their 40s and 
50s, the prevalence was more than 30 %. Prevalence of 
subjects who could not stand with one leg from a 40-cm-
high seat who were aged in their 30s and younger, 40s, 50s, 
Table 1  Mean (SD) values for age, body mass index (BMI), five-times-sit-to-stand test (FTSST) time, walking speed, and two-step test score of 
participants classified by age and sex
a Significantly different (p < 0.05) from values of those aged <40 years
b Significantly different (p < 0.05) from values of those aged in their 40s
c Significantly different (p < 0.05) from values of those aged in their 50s
d Significantly different (p < 0.05) from values of those aged in their 60s
e Significantly different (p < 0.05) from values of those aged in their 70s
Age strata (years) n Age (years) BMI (kg/m2) FTSST time (s) Walking speed (m/s) Two-step test score
Men
 <40 23 32.8 (4.8) 24.5 (3.3) 6.96 (1.33) 1.26 (0.22) 1.49 (0.14)
 40–49 38 44.7 (3.1) 25.4 (5.1) 6.79 (2.41) 1.25 (0.25) 1.41 (0.15)
 50–59 82 55.2 (2.5) 24.2 (3.3) 7.11 (1.47) 1.25 (0.26) 1.36 (0.13)a
 60–69 137 64.3 (2.7) 23.8 (3.4) 8.10 (2.51) 1.16 (0.26) 1.29 (0.15)ab
 70–79 139 74.3 (2.8) 23.4 (2.9) 8.72 (2.18)bc 1.02 (0.24)abcd 1.20 (0.16)abcd
 ≥80 94 83.8 (3.1) 22.3 (3.0) 11.48 (4.72)abcde 0.81 (0.28)abcde 1.06 (0.22)abcde
 Total 513 66.2 (13.7) 23.6 (3.4) 8.57 (3.17) 1.08 (0.30) 1.25 (0.20)
Women
 <40 36 34.4 (4.8) 20.7 (3.0) 7.11 (1.26) 1.28 (0.17) 1.40 (0.14)
 40–49 85 44.9 (2.9) 21.9 (3.2) 7.19 (1.64) 1.25 (0.22) 1.35 (0.11)
 50–59 195 54.7 (2.9) 23.0 (4.1) 7.10 (1.94) 1.26 (0.22) 1.35 (0.13)
 60–69 309 64.7 (2.9) 22.8 (3.4) 7.90 (2.31) 1.18 (0.23)c 1.28 (0.18)abc
 70–79 303 74.3 (2.9) 23.3 (3.3) 9.44 (3.57)abcd 1.02 (0.28)abcd 1.16 (0.18)abcd
 ≥80 134 83.1 (3.0) 22.0 (3.4) 11.89 (4.60)abcde 0.75 (0.28)abcde 0.97 (0.23)abcde
 Total 1062 65.3 (12.6) 22.7 (3.5) 8.58 (3.31) 1.11 (0.30) 1.23 (0.21)
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60s, 70s, and 80 years and older were 8.5, 13.8, 21.3, 32.9, 
53.5, and 78.1 %, respectively, indicating that the preva-
lence increased according to age, similar to the two-step 
test; even in subjects aged in their 40s and 50s, the preva-
lence was around 20 %. Prevalence of 25-question GLFS 
score ≥7 in participants aged in their 30s and younger, 40s, 
50s, 60s, 70s, and 80 years and older were 1.7, 9.1, 11.4, 
17.4, 27.9, and 50.0 %, respectively, indicating the overall 
prevalence was lower than that of the other two indices, but 
it increased synergistically in those in their 80s and older. 
Regarding the sex difference of the indices in stage 1, 
although there were no significant differences between men 
and women with regard to two-step test score <1.3 and dif-
ficulty with one-leg standing from a 40-cm-high seat in the 
stand-up test, the prevalence of 25-question GLFS score 
≥7 in women was significantly higher than that in men 
(p < 0.05).
Table 3 shows the results of logistic regression analysis 
using immobility described by slow FTSST time or slow 
walking speed as the objective factor and the presence or 
absence of new indices in stage 1 for a decline in mobil-
ity as explanatory factors, after adjusting for age (+1 year), 
Table 2  Prevalence of indices in the locomotive syndrome risk test 
(stage 1): two-step test score <1.3, difficulty with one-leg standing 
from 40-cm-high seat in the stand-up test (either leg), and 25-ques-
tion geriatric locomotive function scale (GLFS) score ≥7 in partici-
pants classified by age and sex
* Significantly different (p < 0.05) from values of men
Age strata  
(years)
Age (years)  
mean (SD)
Two-step test  
score <1.3 (%)
Difficulty with one-leg standing  
from 40-cm-high seat (either leg) (%)
25-question GLFS 
score ≥7 (%)
Men
 <40 32.8 (4.8) 13.0 4.4 4.4
 40–49 44.7 (3.1) 21.1 15.8 10.8
 50–59 55.2 (2.5) 34.6 15.9 7.4
 60–69 64.3 (2.7) 49.3 30.7 12.0
 70–79 74.3 (2.8) 71.7 47.8 19.9
 ≥80 83.8 (3.1) 84.6 78.0 44.0
 Total 66.2 (13.7) 55.6 39.1 18.8
Women
 <40 34.4 (4.8) 19.4 11.1 0.0
 40–49 44.9 (2.9) 31.8 12.9 8.3
 50–59 54.7 (2.9) 31.8 23.6 13.0
 60–69 64.7 (2.9) 52.4 33.9 19.7
 70–79 74.3 (2.9) 78.3 56.2 31.6
 ≥80 83.1 (3.0) 93.8 78.1 54.3
 Total 65.3 (12.6) 58.2 41.3 24.5*
Table 3  Effect of presence of indices in the locomotive syndrome risk test (stage 1) for decline in mobility described by slow five-times-sit-to-
stand test (FTSST) time and slow walking speed
After adjusting for age, sex, body mass index, and regional difference. Presence or absence of indices for stage 1 also was mutually adjusted
CI confidence interval, GLFS geriatric locomotive function scale, OR odds ratio
Indices for decline in mobility Reference OR (95 % CI) p value
FTSST time >12 s
 Two-step test score <1.3 Yes vs. no 3.28 (1.81–5.97) <0.001
 Difficulty with one-leg standing from 40-cm-high seat (either leg) Yes vs. no 1.78 (1.17–2.69) 0.007
 25-question GLFS score ≥7 Yes vs. no 2.51 (1.73–3.62) <0.001
Walking speed <0.8 m/s
 Two-step test score <1.3 Yes vs. no 4.24 (2.18–8.22) <0.001
 Difficulty with one-leg standing from 40-cm-high seat (either leg) Yes vs. no 2.01 (1.35–3.16) 0.001
 25-question GLFS score ≥7 Yes vs. no 2.65 (1.82–3.86) <0.001
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sex (men = 0; women = 1), BMI (+1 kg/m2), and regional 
difference (mountainous area = 0; coastal area = 1). The 
analysis revealed that all three indices in stage 1 indepen-
dently predicted immobility described by both slow FTSST 
time and slow walking speed.
Table 4 shows the association between accumulation of 
the indices in stage 1 and decline in mobility described by 
slow FTSST time or slow walking speed, after adjusting for 
age (+1 year), sex (men = 0; women = 1), BMI (+1 kg/
m2), and regional difference (mountainous area = 0; 
coastal area = 1). The analysis revealed that accord-
ing to an increasing number of indices, the odds ratio of 
both slow FTSST time and slow walking speed increased 
exponentially.
Next, the prevalence of the indices in stage 2 and 
their association with decline in mobility described by a 
slow FTSST time and slow walking speed were assessed 
(Table 5). Overall, the prevalence of two-step test score 
<1.1, difficulty with standing from a 20-cm-high seat using 
both legs in the stand-up test, and 25-question GLFS score 
≥16 were 21.1, 7.9, and 10.6 %, respectively.
Prevalence of two-step test score <1.1 in subjects aged 
in their 30s and younger, 40s, 50s, 60s, 70s, and 80 years 
and older were 0.0, 1.6, 3.3, 11.3, 28.4, and 65.8 %, 
respectively, indicating that the prevalence was less 
than 5 % in those aged in their 50s and younger, around 
10 % in those aged in their 60s, but more than 50 % in 
those aged 80 years and older. Prevalence of subjects 
who could not stand from a 20-cm-high seat using both 
legs who were aged in their 30 s and younger, 40s, 50s, 
60s, 70s, and 80 years and older were 0.0, 0.8, 0.7, 5.0, 
9.9, and 25.1 %, respectively, indicating that the preva-
lence was less than 5 % in those aged in their 60s and 
younger, around 10 % in those aged in their 70s, but 
dramatically increased in those aged 80 years and older. 
Prevalence of 25-question GLFS score ≥16 in partici-
pants aged in their 30s and younger, 40s, 50s, 60s, 70s, 
and 80 years and older were 0.0, 1.7, 3.3, 5.0, 12.9, and 
Table 4  Effect of accumulation of indices (stage 1) for decline in 
mobility
After adjusting for age, sex, body mass index, and regional difference
CI confidence interval, OR odds ratio
 No. of indices OR (95 % CI) p value
Five-times-sit-to-stand test time >12 s
 0 = reference 1.0 –
 1 2.19 (0.98–4.87) 0.055
 2 2.90 (1.30–6.47) 0.009
 3 11.59 (5.18–25.93) <0.001
Walking speed <0.8 m/s
 0 = reference 1.0 –
 1 5.73 (1.71–19.16) 0.005
 2 9.82 (2.96–32.52) <0.001
 3 32.21 (9.64–107.7) <0.001
Table 5  Prevalence of indices in the locomotive syndrome risk test 
(stage 2): two-step test score <1.1, difficulty with standing from 
20-cm-high seat using both legs in the stand-up test, and 25-question 
geriatric locomotive function scale (GLFS) score ≥16 in participants 
classified by age and sex
* Significantly different (p < 0.01) from values of men
Age strata  
(years)
Age, mean (SD)  
years
Two-step test  
score <1.1 (%)
Difficulty with standing  
from 20-cm-high seat (%)
25-question GLFS 
score ≥16 (%)
Men
 <40 32.8 (4.8) 0.0 0.0 0.0
 40–49 44.7 (3.1) 2.6 2.6 0.0
 50–59 55.2 (2.5) 3.7 0.0 1.2
 60–69 64.3 (2.7) 8.8 3.7 6.0
 70–79 74.3 (2.8) 23.9 2.9 8.1
 ≥80 83.8 (3.1) 58.2 16.5 27.5
 Total 66.2 (13.7) 20.1 4.9 9.0
Women
 <40 34.4 (4.8) 0.0 0.0 0.0
 40–49 44.9 (2.9) 1.2 0.0 2.4
 50–59 54.7 (2.9) 3.1 1.0 4.2
 60–69 64.7 (2.9) 12.4 5.5 4.6
 70–79 74.3 (2.9) 30.4 13.1 15.1
 ≥80 83.1 (3.0) 71.1 31.3 39.4
 Total 65.3 (12.6) 21.6 9.4* 11.4
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34.4 %, respectively, indicating that the overall preva-
lence increased according to age; the prevalence was 
less than 5 % in subjects aged in their 60s and younger, 
around 10 % in those aged in their 70s, but dramatically 
increased in those aged 80 years and older. Regarding the 
sex difference of the indices in stage 2, although there 
were no significant differences between men and women 
with regard to two-step test score <1.1 and 25-question 
GLFS score ≥16, the prevalence of difficulty with stand-
ing from a 20-cm-high seat using both legs in the stand-
up test in women was significantly higher than that in men 
(p < 0.01).
Table 6 shows the results of logistic regression analysis 
using immobility described by a slow FTSST time or slow 
walking speed as the objective factor and the presence or 
absence of new indices in stage 2 for decline in mobility 
as explanatory factors, after adjusting for age (+1 year), 
sex (men = 0; women = 1), BMI (+1 kg/m2), and regional 
difference (mountainous area = 0; coastal area = 1). The 
analysis revealed that all three indices in stage 2 inde-
pendently predicted immobility described by both a slow 
FTSST time and slow walking speed. The odds ratios of all 
indices in stage 2 for slow FTSST time and slow walking 
speed were greater than those of all indices in stage 1.
Table 7 shows the association between accumulation 
of the indices in stage 2 and decline in mobility described 
by slow FTSST time or slow walking speed, after adjust-
ing for age (+1 year), sex (men = 0; women = 1), BMI 
(+1 kg/m2), and regional difference (mountainous 
area = 0; coastal area = 1). The analysis revealed that 
according to an increasing number of indices, the odds 
ratio of both slow FTSST time and slow walking speed 
increased exponentially. The odds ratios of accumulation 
of the indices in stage 2 for slow FTSST time and slow 
walking speed were greater than those of accumulation of 
the indices in stage 1.
Discussion
In the present study, we clarified the associations of three 
new indices for immobility, including the two-step test, 
stand-up test, and 25-question GLFS, represented by slow 
FTSST time and slow walking speed. We first tested the 
associations among the three indices by using the clinical 
decision limits for locomotive syndrome risk test stage 1. 
Next, we tested the three indices in stage 2. We clarified the 
age and sex distributions of the prevalence of these three 
indices and found that the three indices in both stages 1 
and 2 significantly and independently predicted a decline 
in mobility and that the accumulation of such indices 
increased the risk of immobility exponentially.
First, we used both FTSST time and 6-m walking speed 
as outcome measures of immobility. As mentioned in 
“Methods”, these two indices are both regarded as predic-
tors for morbidity and disability [10–12, 16]. In the ROAD 
Table 6  Effect of presence of indices in the locomotive syndrome risk test (stage 2) for decline in mobility described by slow five-times-sit-to-
stand test (FTSST) time and slow walking speed
After adjusting for age, sex, body mass index, and regional difference. Presence or absence of indices for stage 2 also was mutually adjusted
CI confidence interval, GLFS geriatric locomotive function scale, OR odds ratio
Indices for decline in mobility Reference OR (95 % CI) p value
FTSST time >12 s
 Two-step test score <1.1 Yes vs. no 3.03 (1.97–4.66) <0.001
 Difficulty with standing from 20-cm-high seat % Yes vs. no 5.87 (3.48–9.89) <0.001
 25-question GLFS score ≥16 Yes vs. no 2.83 (1.77–4.54) <0.001
Walking speed <0.8 m/s
 Two-step test score <1.1 Yes vs. no 4.19 (2.75–6.39) <0.001
 Difficulty with standing from 20-cm-high seat % Yes vs. no 3.40 (1.99–5.82) <0.001
 25-question GLFS score ≥16 Yes vs. no 3.49 (2.15–5.65) <0.001
Table 7  Effect of accumulation of new indices (stage 2) for decline 
in mobility
After adjusting for age, sex, body mass index, and regional difference
CI confidence interval, OR odds ratio
No. of new indices OR (95 % CI) p value
Five-times-sit-to-stand test time >12 s
 0 = reference 1.0 –
 1 2.99 (1.85–4.84) <0.001
 2 12.35 (7.08–21.54) <0.001
 3 46.87 (19.37–113.45) <0.001
Walking speed <0.8 m/s
 0 = reference 1.0 –
 1 3.50 (2.19–5.59) <0.001
 2 12.52 (7.08–22.13) <0.001
 3 61.93 (24.92–153.87) <0.001
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study, we reported that the longer the standing time, the 
higher the incidence of disability [13] and that slow walk-
ing speed was also a predictor for the occurrence of dis-
ability [13]. Although we could not clarify the direct 
associations between these new indices and occurrence of 
disability because this study design was cross-sectional, 
these surrogate indices could help predict disability in the 
near future. Therefore, if we could clarify the significant 
associations between these new indices and FTSST time 
and 6-m walking speed, we might clarify the ability to pre-
dict disability indirectly. Based on this hypothesis, we used 
cutoff values of 12 s for FTSST time [13] and 0.8 m/s for 
6-m walking speed [16].
The two-step test was developed to assess walking abil-
ity, including muscle strength, balance, and flexibility of 
the lower limbs. This test was first developed by Muranaga 
and Hirano in 2003 [3, 8]. They compared two-step test 
scores of 108 healthy volunteers (38 men, 70 women; mean 
age 59.0 years) with those of 108 hospital outpatients (56 
men, 52 women; mean age 60.3 years) and found that the 
two-step test score was significantly associated with the 
risk of falling and degree of independence in daily life [7]. 
In the present study, we clarified mean two-step test scores 
in participants classified by age and sex and found mean 
scores of 2.07 in men and 1.87 in women. Scores of men 
were significantly higher than those of women, and age 
differences indicated that scores were significantly lower 
according to age in both men and women. These age and 
sex tendencies are consistent with those reported in a previ-
ous study [3].
Regarding the prevalence of the indices in locomo-
tive syndrome risk test stages 1 and 2, we found that all 
prevalences increased with age. However, the distribution 
of each index seemed to differ. In stage 1, the prevalence 
was highest for a two-step test score <1.3, followed by dif-
ficulty with one-leg standing from a 40-cm-high seat in the 
stand-up test and 25-question GLFS score ≥7. By contrast, 
in stage 2, the prevalence also was highest for a two-step 
test score <1.1, but the prevalence of a 25-question GLFS 
score ≥16 was higher than that of difficulty with standing 
from a 20-cm-high seat using both legs in the stand-up test. 
The different age distributions of these three indices in both 
stages 1 and 2 might be conducive to their mutually inde-
pendent associations with immobility. Our result that these 
three indices in both stages 1 and 2 independently predicted 
immobility shows that all three are important for predicting 
immobility. Furthermore, because these indices indepen-
dently predicted immobility, risk severity may be classi-
fied by a positive number of indices present. In fact, in our 
study, accumulation of indices increased the risk of immo-
bility exponentially, especially accumulation of indices in 
stage 2, which suggests the possibility of categorizing the 
severity of risk for immobility, such as 0, normal; 1, mild; 
2, moderate; 3, severe.
With regard to the 25-question GLFS, there might be 
some concern that it is too cumbersome for older people to 
answer 25 questions. Seichi et al. also proposed a short ver-
sion of the test using only five questions with a cutoff score 
of ≥6, on behalf of a 25-question GLFS score ≥16. They 
selected five questions from the 25-question GLFS using 
the Akaike information criterion (AIC) [17–19]. They 
determined that a cutoff score of 6 had the lowest AIC 
value, representing the model with the best fit, and finally 
concluded that the five-question GLFS can be applied as 
a rapid self-check tool for locomotive syndrome [4]. We 
compared the results of 1535 individuals who completed 
both the 25-question GLFS and five-question GLFS. Sup-
plementary Table 1 shows that these two indices (five-ques-
tion GLFS and 25-question GLFS) have a strong associa-
tion (sensitivity 0.859; specificity 0.985). This result shows 
the possibility of using the five-question GLFS instead of 
the 25-question GLFS as a rapid-check tool for the predic-
tion of immobility.
There are several limitations in the present study. First, 
as mentioned above, our study assessed the usefulness of 
three indices in locomotive syndrome risk test stages 1 and 
2 for predicting immobility using FTSST time and walking 
speed as outcome variables. Although there has been sig-
nificant evidence regarding these outcome measures, such 
as slow FTSST time and slow walking speed, and disabil-
ity [8, 10–13, 16], including our report, the direct associa-
tions of these new indices and occurrence of disability are 
unclear. The proposal of these new indices was published 
in 2013 [3], so there was not enough time to observe future 
occurrence of disability in our cohort. Therefore, we should 
continue to observe our cohort and assess the ability of such 
indices to predict disability directly. Second, although the 
ROAD study includes a large number of participants, these 
participants do not truly represent the general population, 
since the subjects in the present study were recruited from 
only two areas. However, we have already confirmed the 
representativeness of the participants of the ROAD base-
line study to the Japanese population by comparing anthro-
pometric measurements and frequencies of smoking and 
alcohol consumption between participants and the general 
Japanese population [5]. Values for the general population 
were obtained from the 2005 National Health and Nutrition 
Survey conducted by the Ministry of Health, Labour and 
Welfare in Japan [20]. Regarding anthropometric measure-
ments, we found no significant differences between our par-
ticipants and the total Japanese population, except that men 
participants aged 70–74 years in the ROAD study were sig-
nificantly smaller in terms of body structure than the over-
all population (p < 0.05). In addition, proportions of current 
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smokers and current drinkers were significantly higher in 
the general Japanese population than in the study popula-
tion [5], suggesting that participants of the ROAD study 
have healthier lifestyles than the general population. This 
“healthy” selection bias should be taken into consideration 
when using reference values obtained in the ROAD study.
In conclusion, we have assessed whether the proposed 
clinical decision limits of the indices in locomotive syn-
drome risk test stages 1 and 2 could predict immobility 
represented by a slow FTSST time and slow walking speed 
using data from a population-based cohort of the third sur-
vey of the ROAD study. We found that all the indices in the 
locomotive syndrome risk test—the two-step test, stand-up 
test, and 25-question GLFS—could significantly and inde-
pendently predict a decline in mobility and that the accu-
mulation of such indices increased the risk of immobility 
exponentially.
Acknowledgments This work was supported by a Grant-in-Aid for 
H17-Men-eki-009 (Director, Kozo Nakamura), H20-Choujyu-009 
(Director, Noriko Yoshimura), H23-Choujyu-002 (Director, Toru 
Akune), H-25-Choujyu-007 (Director, Noriko Yoshimura), and H25-
Nanchitou(Men)-005 (Director, Sakae Tanaka) of the Ministry of 
Health, Labour, and Welfare; and Scientific Research B23390172, 
B20390182, and Challenging Exploratory Research 24659317 
to Noriko Yoshimura; B23390356, C20591774, and Challenging 
Exploratory Research 23659580 to Shigeyuki Muraki; Challenging 
Exploratory Research 24659666 and 21659349 and Young Scientists 
A18689031 to Hiroyuki Oka; B23390357 and C20591737 to Toru 
Akune; Collaborating Research with NSF 08033011-00262 (Director, 
Noriko Yoshimura) from the Ministry of Education, Culture, Sports, 
Science and Technology in Japan. This study also was supported by 
grants from the Japan Osteoporosis Society (Noriko Yoshimura, Shi-
geyuki Muraki, Hiroyuki Oka, and Toru Akune) and research aid from 
the Japanese Orthopaedic Association (JOA-Subsidized Science Pro-
ject Research 2006-1 & 2010-2; Director, Hiroshi Kawaguchi). The 
authors wish to thank Dr. Takako Nojiri and Mr. Kazuhiro Hatanaka 
of the Gobo Public Health Centre; Dr. Naoki Hirabayashi of the 
Kawakami Clinic in Hidakagawa Town; Mrs. Tomoko Takijiri, Mrs. 
Rie Takiguchi, Mrs. Kyoko Maeda, and other members of the public 
office in Hidakagawa Town; Dr. Shinji Matsuda of the Shingu Pub-
lic Health Centre; Mrs. Tamako Tsutsumi, Mrs. Kanami Maeda, Mrs. 
Megumi Takino, Mrs. Shuko Okada, Mrs. Kazuyo Setoh, Mrs. Chise 
Ryouno, Mrs. Miki Shimosaki, Mrs. Chika Yamaguchi, Mrs. Yuki 
Shimoji, and other members of the public office in Taiji Town for 
their assistance in locating and scheduling participants for examina-
tions. We also thank Ms. Kyoko Yoshimura, Mrs. Toki Sakurai, Mrs. 
Saeko Sahara, and Mr. Noriyuki Oe for their assistance in data reduc-
tion and administration.
Conflict of interest No conflicts of interest have been declared by 
the authors.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
 1. Ministry of Health, Labour and Welfare. The outline of the 
results of National Livelihood Survey (2013). http://www.mhlw.
go.jp/toukei/saikin/hw/k-tyosa/k-tyosa13/dl/06.pdf. Accessed 17 
June 2015
 2. Nakamura K. A “super-aged” society and the “locomotive syn-
drome”. J Orthop Sci. 2008;13(1):1–2.
 3. Locomotive syndrome. In: Locomotive Challenge! Council, edi-
tors. Locomotive syndrome pamphlet 2013. Japanese Orthopae-
dic Association: Tokyo; 2013.
 4. Seichi A, Hoshino Y, Doi T, Akai M, Tobimatsu Y, Iwaya T. 
Development of a screening tool for risk of locomotive syn-
drome in the elderly: the 25-question Geriatric Locomotive 
Function Scale. J Orthop Sci. 2012;17(2):163–72.
 5. Locomotive syndrome. In: Locomotive Challenge! Council, edi-
tors. Locomotive syndrome pamphlet 2015. Tokyo: Japanese 
Orthopaedic Association; 2015 (in press).
 6. Yoshimura N, Muraki S, Oka H, Mabuchi A, En-yo Y, Yoshida 
M, Saika A, Suzuki T, Yoshida H, Kawaguchi H, Nakamura K, 
Akune T. Prevalence of knee osteoarthritis, lumbar spondylosis 
and osteoporosis in Japanese men and women: the research on 
osteoarthritis/osteoporosis against disability study. J Bone Miner 
Metab. 2009;27(5):620–8.
 7. Yoshimura N, Muraki S, Oka H, Kawaguchi H, Naka-
mura K, Akune T. Cohort profile: research on osteoarthritis/
osteoporosis against disability (road) study. Int J Epidemiol. 
2010;39(4):988–95.
 8. Muranaga S, Hirano K. Development of a convenient way to pre-
dict ability to walk, using a two-step test. J Showa Med Assoc. 
2003;63(3):301–8 (in Japanese).
 9. Muranaga S. Evaluation of the muscular strength of the lower 
extremities using the standing movement and clinical applica-
tion. J Showa Med Assoc. 2001;61(3):362–7 (in Japanese).
 10. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, 
Ostir GV, Studenski S, Berkman LF. Lower extremity function 
and subsequent disability: consistency across studies, predictive 
models, and value of gait speed alone compared with the short 
physical performance battery. J Gerontol A Biol Sci Med Sci. 
2000;55(4):M221–31.
 11. Buatois S, Miljkovic D, Manckoundia P, Gueguen R, Miget P, 
Vançon G, Perrin P, Benetos A. Five times sit to stand test is a 
predictor of recurrent falls in healthy community-living subjects 
aged 65 and older. J Am Geriatr Soc. 2008;56(8):1575–7.
 12. Bohannon RW. Reference values for the five-repetition sit-to-
stand test: a descriptive meta-analysis of data from elders. Per-
cept Mot Skills. 2006;103(1):215–22.
 13. Akune T, Muraki S, Oka H, Tanaka S, Kawaguchi H, Tokimura 
F, Yoshida H, Suzuki T, Nakamura K, Yoshimura N. Inci-
dence of certified need of care in the long-term care insurance 
system and its risk factors in the elderly of Japanese popu-
lation-based cohorts: the ROAD study. Geriatr Gerontol Int. 
2014;14(3):695–701.
 14. Mong Y, Teo TW, Ng SS. 5-repetition sit-to-stand test in sub-
jects with chronic stroke: reliability and validity. Arch Phys Med 
Rehabil. 2010;91(3):407–13.
 15. Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings 
S, Ensrud K, Lewis C, Cawthon PM, Marcus R, Marshall LM, 
McGowan J, Phipps K, Sherman S, Stefanick ML, Stone K. 
Design and baseline characteristics of the osteoporotic frac-
tures in men (MrOS) study—a large observational study of the 
determinants of fracture in older men. Contemp Clin Trials. 
2005;26(5):569–85.
 16. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah 
KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, 
905Association between new indices in the locomotive syndrome risk test and decline in mobility…
1 3
Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, 
Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akish-
ita M, Arai H. Sarcopenia in Asia: consensus report of the 
Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 
2014;15(2):95–101.
 17. Akaike H. Information theory and an extension of the maximum 
likelihood principles. In: Petrov B, Caski F, editors. The second 
international symposium on information theory. Budapest: Aka-
demia Kiado; 1973. p. 267–81.
 18. Sakamoto Y, Ishiguro M, Kitagawa G. Akaike information crite-
rion statistics. Dordrecht: Reidel; 1986.
 19. FORTRAN Program CATDAP-02. In: Sakamoto Y, ed. Categori-
cal data analysis by AIC. Tokyo: KTK Scientific Publishers, Klu-
wer Academic Publishers; 1991: 163–206.
 20. Ministry of Health, Labour and Welfare. The report of National 
Health and Nutrition Survey (2005). http://www.mhlw.go.jp/
bunya/kenkou/eiyou07/dl/01-04.pdf. Accessed 17 June 2015
